Navigation Links
BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects
Date:6/17/2013

TEL AVIV, Israel, June 17, 2013 /PRNewswire/ --

During its meeting on June 5, 2013, the Board of Governors of the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation, approved $10.95 million in funding for fourteen new projects between Israeli and American companies. In addition to the grants from BIRD, the projects will access private sector funding, boosting the total value of all projects to approximately $33 million. The semi-annual meeting was held at the campus of the National Institute of Standards and Technologies (NIST), Gaithersburg, MD.

The BIRD Foundation promotes collaboration between Israeli and American companies in various technological fields for the purpose of joint product development.  In addition to providing conditional grants of up to $1 million for approved projects, the Foundation assists by working with companies to identify potential strategic partners and facilitate introductions.

The fourteen projects approved by the Board of Governors are in addition to the 863 projects which the BIRD Foundation has approved for funding during its 36 year history. To date, BIRD's total investment in these projects has been over $300 million, helping to generate direct and indirect sales of more than $10 billion.

The approved projects are as follows:

  • Accells Technologies Ltd. (Israel) and 41st Parameter, Inc. (Scottsdale, AZ) will develop a capability for mobile authentication with device detection to fight cyber-attacks.
  • Asymmetric Medical Ltd (Israel) and Flextronics (Irving ,CA) will develop asymmetric laser tools for surgery.
  • Curapipe (Israel) and Milliken  (Spartanburg, SC ) will develop a leakage cure system for urban water pipes.
  • Dor Chemicals Ltd. (Israel) and Turbulent Energy LLC (Buffalo, NY) will develop and commercialize diesel/methanol hybrid fuels.
  • Freshpoint Quality Assurance Ltd (Israel) and West Pharmaceutical Services (Exton, PA) will develop novel printable integrated threshold indicators for monitoring the quality of unit level pharmaceutical products.
  • Hanita Coatings (Israel) and Whirlpool Corporation (Harbor, MI) will develop super-efficient thermal insulation for refrigerator doors through an integrated vacuum insulation technology.
  • InSightec Ltd, (Israel) and Focused Ultrasound Surgery Foundation (Charlottesville, VA) will develop non-invasive brain surgery for movement disorders..
  • iReveal Design Automation (Israel) and Forte Designs Systems (San Jose, CA) will develop an electronic system level verification product.
  • Kadoor Microelectronics and Broadcom (Irvine, CA) will develop a RF MEMs switch.
  • Nortec (Israel) and Gas Technology Institute (Des Plaines, IL) will develop and manufacture an advanced barcoding solution for underground asset lifecycle tracking.
  • Novoxel (Israel) and Edge Systems Corporation (SignalHill, CA) will develop an aesthetic/medical product line based on novel thermal technology
  • Rambam Health Corporation (Israel) and Orlucent (San Francisco, CA) will develop a molecular imaging system for melanoma detection.
  • TransBioDiesel (Israel) and Heliae Development (Gilbert, AZ) will develop high value esters for nutraceuticals using 3rd generation enzymatic technology.
  • Water Flow Tech (Israel) and Mueller Water Products (Atlanta, GA) will develop a capability for low flow detection.

Dr. Eitan Yudilevich, Executive Director of the BIRD Foundation, said: "In this cycle, BIRD's Board of Governors approved a relatively large number of joint, innovative projects between U.S. and Israeli companies, in diverse sectors, including several  areas of high national priority for both countries, such as: cyber security, alternative fuels, energy efficiency and water technologies."

Mr. Phillip Singerman, Associate Director for Innovation and Industry Services at the National Institute of Standards and Technology (NIST), and co-Chairman of BIRD Board of Governors said: "The funded projects reflect the continuing evolution of the BIRD program, especially by engaging small and medium size U.S. firms. Eight out of the fourteen U.S. grantee companies are SMEs, an indication of the growing importance of the connection to the global marketplace".

Mr. Avi Hasson, Chief Scientist at the Ministry of Economy and co-Chairman of the Board said: "The BIRD Foundation is an excellent example of the potential which comes from international cooperation in research and development. Past projects' successes and the high level of the projects we approved at the recent Board meeting indicate that such cooperation leads to opportunities for companies to break into global markets, increases jobs and stimulates economic growth."

The deadline for submission of Executive Summaries for the next BIRD cycle is on September 10, 2013. Approval of projects will take place in December 2013.

About the BIRD Foundation

The BIRD (Binational Industrial Research and Development) Foundation works to encourage cooperation between Israeli and American companies in the various areas of technology, and provides free assistance in locating strategic partners from both countries for developing joint products.

The BIRD Foundation supports projects without receiving any rights in the participating companies or in the project itself. The financial assistance is repaid as royalties from sales. The Foundation provides support of up to 50% of a project's budget, beginning with R&D and ending with the initial stages of sales and marketing. The Foundation shares the risk and does not demand that the investment be repaid if the project fails to reach the sales stage.

The BIRD Foundation works in full cooperation with the Chief Scientist's Office at the Ministry of Economy in Israel, and with the U.S. Commerce Department's National Institute of Standards and Technology (NIST).

Dr. Eitan Yudilevich, Executive Director, The BIRD Foundation

eitan@birdf.com

Tel: +972-3-6988300



'/>"/>
SOURCE The BIRD Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012
2. Cephasonics Inks Distribution Deal With Tritech To Extend Worldwide Sales Reach Into Israel
3. Israel Makov Appointed Chairman of Sun Pharma Board
4. Beth Israel Deaconess Medical Center, Harvard Medical School Study Confirms Cannabis Sciences Approach to Development of CS-TATI-1 to Inhibit Kaposi Sarcoma
5. Israeli Innovation Shown to Demonstrate Reduction in Headaches and Neck Pain
6. SafeCode Drug Technologies Corp Signs an Agreement With INTOVISION PRODUCT DEVELOPMENT & DESIGN (An Israeli Product Development Co) to Manufacturers the Worlds First Voice Recognition Drug Safety Application Prototype
7. Study Results of Dune Medicals Breast Biopsy System Presented at the Annual Meeting of the Israel Society of Breast Imaging
8. Immune Pharmaceuticals CEO to Chair BIO International Panel "Can Israel Become the Next Biotech Startup Nation?"
9. Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court
10. Israel Brain Technologies Announces Israels 1st International Brain Technology Conference
11. Oramed Pharmaceuticals Awarded Grant by the Office of the Chief Scientist of Israel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners is ... sequencing and genomics experience, as Vice President of North American Capital Sales at ... for leading the sales team in the commercialization of the HTG EdgeSeq system and ...
Breaking Medicine News(10 mins):